Bio Marketing
Driving Success in Pharma Communication The partnership between Viseven and SpotMe creates a unique point of view on the HCP engagement and B2B event orga...
June 21, 2023 | News
Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...
May 31, 2023 | News
New distribution center officially opened in Enfield, Connecticut Targeted strengthening of the supply chain and of the customer focus throughout the Am...
May 11, 2023 | News
Marketing Authorization granted for Tibsovo® as the first and only approved IDH1 targeted therapy in Europe IDH1-mutate...
May 11, 2023 | Regulatory
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...
May 09, 2023 | News
Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-...
May 05, 2023 | News
Hainan Asieris' acquisition of the Drug Distribution Licence is a critical step towards improvement in the quality of drug circulation services, standardiz...
April 11, 2023 | News
At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...
March 31, 2023 | News
Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...
March 28, 2023 | News
– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...
March 09, 2023 | News
Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...
March 07, 2023 | News
Emphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization Reinforces im...
March 06, 2023 | News
The two companies have been jointly engaged in promotional activities for MS treatments in Japan. However, since a certain objective has been achieved rega...
March 02, 2023 | News
Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – - Karyopharm Therapeutics Inc. (Nasda...
February 22, 2023 | News
Most Read
Bio Jobs
News